Wall Street analysts forecast that Anthem Inc (NYSE:ANTM) will report earnings of $2.21 per share for the current quarter, according to Zacks. Seven analysts have issued estimates for Anthem’s earnings, with the highest EPS estimate coming in at $2.29 and the lowest estimate coming in at $2.14. Anthem posted earnings of $1.29 per share in the same quarter last year, which would suggest a positive year over year growth rate of 71.3%. The firm is scheduled to issue its next earnings report on Wednesday, January 30th.
According to Zacks, analysts expect that Anthem will report full year earnings of $15.66 per share for the current year, with EPS estimates ranging from $15.60 to $15.71. For the next financial year, analysts expect that the firm will post earnings of $17.59 per share, with EPS estimates ranging from $17.21 to $18.00. Zacks’ EPS calculations are an average based on a survey of research firms that that provide coverage for Anthem.
Anthem (NYSE:ANTM) last issued its quarterly earnings data on Wednesday, October 31st. The company reported $3.81 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $3.70 by $0.11. Anthem had a return on equity of 13.99% and a net margin of 4.98%. The business had revenue of $22.98 billion for the quarter, compared to the consensus estimate of $22.85 billion. During the same quarter last year, the business posted $2.65 EPS. The firm’s revenue was up 4.0% compared to the same quarter last year.
ANTM has been the topic of several recent research reports. Citigroup downgraded Anthem from a “buy” rating to a “neutral” rating and set a $162.00 price target on the stock. in a research note on Monday, September 10th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $316.00 target price on shares of Anthem in a research report on Friday, October 12th. Morgan Stanley raised Anthem from an “equal weight” rating to an “overweight” rating and lifted their target price for the company from $273.00 to $368.00 in a research report on Wednesday, September 5th. Credit Suisse Group lifted their target price on Anthem from $284.00 to $311.00 and gave the company an “outperform” rating in a research report on Tuesday, September 4th. Finally, BMO Capital Markets lifted their target price on Anthem from $300.00 to $310.00 and gave the company a “buy” rating in a research report on Thursday, November 1st. Four equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. The company currently has an average rating of “Buy” and a consensus target price of $300.33.
Shares of ANTM traded down $12.28 during midday trading on Monday, hitting $280.64. The stock had a trading volume of 86,979 shares, compared to its average volume of 1,423,105. Anthem has a twelve month low of $215.52 and a twelve month high of $300.57. The company has a market capitalization of $75.76 billion, a price-to-earnings ratio of 22.96, a P/E/G ratio of 1.43 and a beta of 0.85. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.53 and a quick ratio of 1.54.
The firm also recently declared a quarterly dividend, which will be paid on Friday, December 21st. Investors of record on Wednesday, December 5th will be issued a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a yield of 1.07%. The ex-dividend date is Tuesday, December 4th. Anthem’s payout ratio is currently 24.92%.
In related news, EVP Peter D. Haytaian sold 4,500 shares of Anthem stock in a transaction dated Tuesday, November 27th. The stock was sold at an average price of $278.48, for a total transaction of $1,253,160.00. Following the completion of the transaction, the executive vice president now owns 47,006 shares in the company, valued at $13,090,230.88. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Thomas C. Zielinski sold 7,826 shares of Anthem stock in a transaction dated Wednesday, November 7th. The stock was sold at an average price of $289.71, for a total value of $2,267,270.46. Following the transaction, the executive vice president now owns 29,466 shares of the company’s stock, valued at approximately $8,536,594.86. The disclosure for this sale can be found here. Insiders have sold 20,826 shares of company stock valued at $5,815,620 in the last quarter. 0.31% of the stock is currently owned by corporate insiders.
Large investors have recently made changes to their positions in the company. Strategic Wealth Partners Ltd. grew its stake in shares of Anthem by 13.7% in the third quarter. Strategic Wealth Partners Ltd. now owns 4,264 shares of the company’s stock worth $1,169,000 after purchasing an additional 513 shares during the last quarter. Great Lakes Advisors LLC increased its stake in Anthem by 53.2% in the 3rd quarter. Great Lakes Advisors LLC now owns 55,944 shares of the company’s stock valued at $15,331,000 after buying an additional 19,423 shares during the last quarter. Vanguard Group Inc. increased its stake in shares of Anthem by 2.9% during the 3rd quarter. Vanguard Group Inc. now owns 18,729,474 shares of the company’s stock worth $5,132,811,000 after purchasing an additional 532,579 shares during the last quarter. Morgan Stanley boosted its holdings in Anthem by 65.9% in the 3rd quarter. Morgan Stanley now owns 676,812 shares of the company’s stock valued at $185,481,000 after purchasing an additional 268,900 shares during the period. Finally, Legal & General Group Plc raised its position in shares of Anthem by 2.7% during the 3rd quarter. Legal & General Group Plc now owns 1,322,846 shares of the company’s stock valued at $362,507,000 after buying an additional 34,478 shares in the last quarter. Institutional investors own 87.12% of the company’s stock.
Anthem Company Profile
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.